基本分析数据在慢性阻塞性肺病恶化中的预后有用性
Sandra Martínez-Gestoso1, María-Teresa García-Sanz2, José-Martín Carreira3
1Emergencies Department Salnés Couny Hospital, Vilagarcía de Arousa, Spain.
Open respiratory archives
|October 11, 2023
概括
在因COPD恶化而住院的患者中,CRP/白蛋白比率升高,尿素和热素T预测短期结果不佳和死亡风险增加. 这些发现有助于优化患者管理和治疗策略.
科学领域:
- 肺部医学 肺部医学
- 临床化学 临床化学
- 生物标志物研究 生物标志物研究
背景情况:
- 慢性阻塞性肺病 (COPD) 导致严重的发病率,死亡率和医疗保健费用.
- 确定COPD恶化中可治疗的特征对于优化患者管理至关重要.
- 目前的研究缺乏可靠的数据,用于在COPD治疗中系统地利用生物标志物.
研究的目的:
- 评估COPD恶化患者常规临床和分析参数的短期预后价值.
- 为了确定COPD恶化的住院治疗后不良结果的关键指标.
主要方法:
- 从2016年到2018年进行了一项多中心前性观察研究.
- 包括的患者因COPD恶化而入院,并提供了知情同意.
- 不良进展被定义为长时间住院,住院死亡率或早期再入院;30天死亡率也被评估.
主要成果:
- 这项研究包括615名患者 (平均年龄73.9岁,86.2%是男性).
- 58%的患者经历了不良进展,在出院后1个月内死亡率为6.7%.
- 多变量分析确定CRP/白蛋白比率升高 (OR 1.008),尿素 (OR 1.01) 和素T (OR 2.21) 作为不良进展和1个月死亡率的预测因素.
结论:
- 升高的CRP/白蛋白比率,尿素和热素T是COPD恶化患者短期不良预后指标.
- 这些发现表明心血管并发症和全身炎症在恶化结果中的作用.
- 这些生物标志物有可能被纳入常规临床实践,用于风险分层.
更多相关视频
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
218
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
218
01:28Physical Assessment of the Respiratory Tract I: Health History
237
Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
237